Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Do you recommend radiation in a patient with BAP1Tumor Predisposition Syndrome with prior RCC with recurrent brain met after previous resection?
History of indolent lung mesothelioma, multiple skin BCCs and breast cancer.
Related Questions
In post-prostatectomy patients where urinary continence is never achieved, how and when would you plan RT when it is clinically indicated?
How do you talk to patients with intermediate-risk prostate cancer deciding between LDR brachytherapy (monotherapy) vs HDR mono vs SBRT vs EBRT, in terms of the comparative side effect profile of each approach?
As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
Is there evidence that prostatectomy improves overall survival in local recurrence of prostate cancer post-definitive radiation?
Is there any way to safely treat patients with mCRPC with 177-Lu PSMA who are on hemodialysis?
For a patient with stage IIB pure seminoma s/p orchiectomy who has bilateral RP adenopathy, do you also cover the contralateral iliac nodes in the dog-leg field?
Would you ever omit or reduce prostate bed radiation in a post-prostatectomy patient who develops recurrence in pelvic LNs?
In patients who have residual bladder tumors after maximal TURBT, would you boost the GTV above typical doses, 55 Gy/20 fractions or 64 Gy/32 fractions, assuming you can meet constraint?
Are there any contraindications to Pluvicto therapy you personally use, given that there are none directly provided by the manufacturer?
How long would you delay prostate radiation following use of a paclitaxel-eluting balloon dilator (optilume) for management of a recurrent urethral stricture after TURP?